CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Hysteroscopic Intrauterine Morcellation for Benign Intrauterine Pathologies: Clinical Effectiveness and Guidelines

Last updated: October 23, 2018
Project Number: RB1267-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of hysteroscopic intrauterine morcellation for the removal of benign intrauterine pathologies?
  2. What are the evidence-based guidelines regarding the management of an unsuspected malignancy diagnosed in patients who have previously undergone hysteroscopic intrauterine morcellation for the intention of the removal of benign intrauterine pathologies?

Key Message

One evidence-based guideline was identified regarding the clinical effectiveness of hysteroscopic intrauterine morcellation for benign intrauterine pathologies. No relevant clinical studies were identified regarding the clinical effectiveness of hysteroscopic intrauterine morcellation for the removal of benign intrauterine pathologies.